Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
- Status
- COMPLETED
- Phase
- PHASE3
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
FCR Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma
- Status
- UNKNOWN
- Phase
- PHASE3
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.
- Status
- COMPLETED
- Phase
- PHASE3
S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
- Status
- TERMINATED
- Phase
- PHASE1
T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2